As of early 2026, the scientific consensus on CBD (cannabidiol) for anxiety is cautiously optimistic but emphasizes the need for high-quality, clinical-grade products. Ongoing studies, including those at major research institutions like the University of Florida, are currently testing doses ranging from 50 mg to 150 mg per day to determine efficacy. While many users report a significant reduction in "social anxiety" and improved sleep, CBD is not a "magic pill." Its effectiveness often depends on the "entourage effect," where it works best alongside other minor cannabinoids. It is important to note that CBD does not produce the "high" associated with THC, making it a preferred choice for those seeking non-psychoactive relief. However, in 2026, experts warn that over-the-counter CBD oils are often under-dosed; for clinical anxiety, a doctor's consultation is still recommended to ensure the CBD won't interfere with other medications, such as blood thinners or antidepressants.